Russia is ready to conduct clinical trials in Ukraine of a COVID-19 vaccine combining its Sputnik V with a vaccine developed by AstraZeneca together with Oxford University, the head of Russian Direct Investment Fund (RDIF) said on Saturday.
Russia’s sovereign RDIF, which is marketing the Sputnik V vaccine abroad, announced in December trials to test a combination of the AstraZeneca vaccine with the Sputnik V shot to see if this can boost the efficacy of the British drugmaker’s vaccine.
Sputnik V is the first registered vaccine against COVID-19.
However, Only 1 per cent of Argentinian citizens, who received the Russia-developed Sputnik V vaccine against the coronavirus, has shown a mild adverse reaction to the shot, the TN broadcaster reported on Saturday, citing the country’s Health Ministry.
According to the media outlet, 317 patients reported fever and headaches of the total 32,013.